Teladoc Health Provides Updated Start Time for Fourth Quarter 2023 Earnings Call on February 20, 2024

The partnership enables Teladoc Health's employer clients and members more streamlined and fully integrated access to Carrum's value-based Centers of Excellence network for specialty care SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- Carrum Health, the leader in value-based Centers of Excellence (COE) for specialty care, today announced a strategic partnership with Teladoc Health (NYSE:TDOC), the global leader in virtual care. The new arrangement will allow Teladoc Health's providers to seamlessly refer eligible members needing specialty care into Carrum's nationwide network of rigorously vetted, high quality providers. This means employers can contract directly through Teladoc Health's Conn

CHICAGO, March 12, 2025 (GLOBE NEWSWIRE) -- Cylinder, the leading virtual digestive health provider, today announced its partnership with Teladoc Health (NYSE:TDOC), the global leader in virtual care, to expand access to high-quality, personalized gastrointestinal care. Through this collaboration, Teladoc Health's health plan and employer customers can easily provide members access to Cylinder's evidence-based digestive health platform, through streamlined administrative services and integration enablement. Digestive health conditions affect up to 70 million Americans and drive significant healthcare costs — up to $136 billion annually. Cylinder's platform delivers precise diagnoses and p

PURCHASE, NY, March 11, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the expansion of its connected care partnerships across new care categories including digestive health, centers of excellence, fertility and family building. In addition, recently announced technology integrations will empower Teladoc Health's care providers and coaches to view members' eligibility for these services and seamlessly refer them to appropriate partner programs at the point of care. The latest enhancements are part of Teladoc Health's integrated care segment strategy to fuel use of its services and leverage the company's clinical strength and produ

Goldman initiated coverage of Teladoc with a rating of Buy and set a new price target of $14.00

Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously

Cantor Fitzgerald initiated coverage of Teladoc with a rating of Overweight and set a new price target of $22.00

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

4 - Teladoc Health, Inc. (0001477449) (Issuer)

144 - Teladoc Health, Inc. (0001477449) (Subject)

144 - Teladoc Health, Inc. (0001477449) (Subject)

S-8 - Teladoc Health, Inc. (0001477449) (Filer)

Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret

PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

After spending two decades successfully scaling multiple healthcare technology companies, Perez joins Big Health to accelerate the commercial coverage and reimbursement for digital therapeutics Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced the appointment of Gabriela Perez as Chief Commercial Officer. In her new role, Perez will oversee Big Health's global commercial growth and strategy, including sales, client management, strategic partnerships, and new markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220203005297/en/Big Health Chief Commercial Office

PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 ("Full Year 2024") and three months ended December 31, 2024 ("Fourth Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 ("Full Year 2023") and three months ended December 31, 2023 ("Fourth Quarter 2023"). Full Year and Fourth Quarter 2024 Highlights Full Year 2024 revenue of $2,569.6 million, down 1% year-over-year, and Fourth Quarter 2024 revenue of $640.5 million, down 3% year-over-yearFull Year 2024 net loss of

PURCHASE, NY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release fourth quarter 2024 results on Wednesday, February 26, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 259200. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=72270. A live audio webcast will also be available online at http

PURCHASE, NY, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended September 30, 2024 ("Third Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2023 ("Third Quarter 2023"). Third Quarter 2024 Highlights Third Quarter 2024 revenue of $640.5 million, down 3% year-over-yearThird Quarter 2024 net loss of $33.3 million, or $0.19 per shareThird Quarter 2024 adjusted EBITDA of $83.3 million, down 6% year-over-yearIntegrated Care segment revenue of $383.7 million, up 2% year-over-year, and adjusted EBIT

SC 13G - Teladoc Health, Inc. (0001477449) (Subject)

SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)